ClinicalTrials.gg
Active, not recruitingNCT07920406Updated Nov 5, 2026

Hypopressive-Core Stabilization With and Without Whole-Body Vibration in Postpartum Pelvic Girdle Pain

An interventional study of Hypopressive-core stabilization exercises combined with whole-body vibration and hypopressive and core stabilization in Postpartum Pelvic Girdle Pain, sponsored by University of Management and Technology Lahore. Active, not recruiting at 1 site in Pakistan. Open to female participants aged 22 Years to 40 Years. Per ClinicalTrials.gov, last updated 2026-11-05.

Sponsored by University of Management and Technology Lahore · Not applicable, Interventional, and Treatment

Updated Nov 5, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
22 Years to 40 Years
Sex
Female
01

Study summary

Pregnancy-related pelvic girdle pain is one of the most frequent musculoskeletal complications of pregnancy and the postpartum period. Its prevalence during pregnancy ranges between 20% and 70%, and about 10% of women still have symptoms beyond three months after delivery (persistent postpartum pelvic girdle pain). It limits walking, stair-climbing, prolonged standing, lifting and turning in bed, just when the demands of caring for a newborn are highest. Hypopressive exercise combines diaphragmatic apnea with a costal expansion manoeuvre to co-activate the transversus abdominis and pelvic floor muscles, core stabilization restores lumbopelvic neuromuscular control, and whole-body vibration (WBV) enhances recruitment of trunk and pelvic stabilizers. However, the combination of these approaches has not yet been investigated in postpartum pelvic girdle pain. This randomized clinical trial will compare hypopressive-core stabilization with WBV (Group A) against hypopressive-core stabilization alone (Group B) on pain, mobility and disability. Thirty postpartum women (15 per group) will be recruited by convenient sampling from physiotherapy centers in Lahore and randomly allocated using sealed opaque envelopes. Both groups will attend 3 supervised sessions per week for a total of 8 weeks (24 sessions), each preceded by a moist hot pack for 15 minutes. Each session combines progressive hypopressive postures with core stabilization exercises (squats, bridge and push-up positions); in Group A the core exercises are performed on a vibrating platform at 25 Hz and 2 mm amplitude. Pain (NPRS), pelvic girdle disability (PGQ) and functional mobility (Timed Up and Go) will be measured by a blinded assessor at baseline, end of week 4 and end of week 8. The whole study will be completed within 8 months after synopsis approval. The findings can assist physiotherapists in implementing evidence-based treatment strategies and contribute to better maternal health outcomes for postpartum women.

02

Conditions studied

  • Postpartum Pelvic Girdle Pain

Browse trials for

Keywords

  • Postpartum Pelvic Girdle Pain
  • Pain
  • Disability
  • Hypopressive-Core Stabilization
  • Mobility
  • Whole-Body Vibration
03

In context

Pain

10,054 studies on the registry are indexed under Pain; 1,649 are open to participants now.

This study's enrollment of 30 is below the median of 66 across 8,493 interventional studies indexed under Pain.

Browse Pain studies →

Lead sponsor

University of Management and Technology Lahore is the lead sponsor of 39 studies on the registry; 20 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
22 Years to 40 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Postpartum women aged 22 to 40 years. Pain located between the posterior iliac crest and the gluteal fold, with or without spread to the back of the thigh and/or the pubic symphysis.

Between 6 weeks and 12 months after delivery (puerperium recovery phase). Pain that gets worse with weight bearing, climbing stairs, turning in bed, walking, or parting the legs.

Delivered vaginally. Pain score of 3 to 6 on the Numeric Pain Rating Scale (NPRS). At least 3 of 5 standard clinical tests positive (Posterior Pelvic Pain Provocation, Active Straight Leg Raise, FABER, Gaenslen's, and pelvic compression/distraction), confirming pelvic girdle dysfunction.

Pelvic Girdle Questionnaire (PGQ) score of 28/75 or higher, indicating at least moderate disability.

between 18 and 35.4 kg/m².

Exclusion criteria

Exclusion Criteria:

Nerve-related pain that can mimic pelvic girdle pain (for example, lumbar disc herniation or radiculopathy).

History of pelvic fracture or severe pelvic trauma, or sciatica due to osteoporosis or other bone disease.

Low back pain or pelvic pain that was already present before the index pregnancy.

Current pregnancy. Any systemic, metabolic, neurological, or psychiatric condition that would interfere with participation, or active .

Acute deep vein thrombosis, recent pelvic or abdominal surgery, uncontrolled cardiovascular disease, or implanted electronic devices.

Inflammatory joint disease such as ankylosing spondylitis or rheumatoid arthritis.

Lumbar spine pathology such as disc herniation, nerve root compression, or spondylolisthesis

Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Clinically significant

Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    Hypopressive-core stabilization exercises combined with whole-body vibration

    Group A (HCS + WBV): Hypopressive-core stabilization exercises combined with whole-body vibration. The hypopressive part uses progressive postures (lying, sitting, kneeling, quadruped, and standing) with diaphragmatic breathing and breath-holds (apnea) that build from 15 to 30 seconds, in 30-minute sessions. The core part uses squats, bridge, and push-up positions on a vibrating platform at 25 Hz and 2 mm amplitude, held for 30 seconds in weeks 1-4 and 60 seconds in weeks 5-8, with two repetitions and 30 seconds of rest between them. Each session includes a 5-minute warm-up and cool-down

    Other: Hypopressive-core stabilization exercises combined with whole-body vibration

  • Active comparator
    hypopressive and core stabilization

    Group B (HCS only): The same hypopressive and core stabilization programme, with identical exercises, repetitions, and progression, but performed without any vibration

    Other: hypopressive and core stabilization

Interventions

  • OtherHypopressive-core stabilization exercises combined with whole-body vibration

    Group A (HCS + WBV): Hypopressive-core stabilization exercises combined with whole-body vibration. The hypopressive part uses progressive postures (lying, sitting, kneeling, quadruped, and standing) with diaphragmatic breathing and breath-holds (apnea) that build from 15 to 30 seconds, in 30-minute sessions. The core part uses squats, bridge, and push-up positions on a vibrating platform at 25 Hz and 2 mm amplitude, held for 30 seconds in weeks 1-4 and 60 seconds in weeks 5-8, with two repetitions and 30 seconds of rest between them. Each session includes a 5-minute warm-up and cool-down.

  • Otherhypopressive and core stabilization

    Group B (HCS only): The same hypopressive and core stabilization programme, with identical exercises, repetitions, and progression, but performed without any vibration

06

What researchers measure

Primary outcomes

  1. Numeric Pain Rating Scale (NPRS)

    A simple 11-point scale where participants rate their current pain from 0 to 10. 0 means no pain; 1-3 is mild pain (nagging, annoying, interfering little with daily activities); 4-6 is moderate pain (interferes significantly with daily activities); and 7-10 is severe pain (disabling, unable to perform daily activities

    Time frame: baseline after 8 week

  2. Pelvic Girdle Questionnaire (PGQ)

    The first condition-specific questionnaire for women with pregnancy-related pelvic girdle pain. It has 25 items scored from 0 to 3: 20 on activity limitations and 5 on symptoms, for a maximum of 75. The total is converted to a percentage, where 0% means no disability and 100% means severe disability. It has high reliability (ICC 0.93 for activity, 0.91 for symptoms) and is recommended as a primary outcome measure in this population

    Time frame: baseline after 8 week

  3. Timed Up and Go (TUG) test

    The participant stands up from a standard armchair (about 46 cm high) on the command "go," walks 3 metres at a brisk pace, turns, walks back, and sits down. The time is recorded in seconds. The test is a brief measure of functional mobility. Use the same standardized procedure at each assessment and interpret results alongside the participant's symptoms and other outcome measures.

    Time frame: baseline after 8 week

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Yes

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

Time frame: The results data collected , de-identified individual participant data will be shared.

Access criteria: : The data can be requested from the corresponding author

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2026 (actual). Primary completion is estimated for Dec 2026, 2 months after the start.

Of 3,731 non-industry interventional studies with no phase under Pain, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 23. This study's planned 2 months is below that.

Counting every sponsor, half of 3,830 studies reached it within 10 months; a quarter within 4 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 28, 2026
First posted
Nov 5, 2026
StartActual
Oct 28, 2026
Primary completionEst.
Dec 31, 2026
CompletionEst.
Dec 31, 2026
Last update
Nov 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 5, 2026
Show all 1 update
  1. Nov 5, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07920406
Lead sponsor
University of Management and Technology Lahore
Responsible party
Rabia Majeed (Assistant Professor, University of Management and Technology Lahore) — Principal investigator
First posted
Nov 5, 2026
Start date
Oct 28, 2026
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Nov 5, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion